Traumas and age-related changes in bone tissue and joints determine numerous impairments: pains, edema, stiffness greatly affect the quality of life. It should be admitted that while orthopedics and surgery were not particularly successful in the treatment of diseases of the osteoarticular apparatus: the results of standard methods are achieved slowly and in general are very modest.
Creation of the regenerative complex MeaPlasma became a real breakthrough in the surgical and conservative treatment of most pathologies.
Autoplasmotherapy in orthopedics: what is the breakthrough?
Both therapists working with the complex and the patients who follow sessions of autoplasmotherapy note:
- Gradual reduction of pain and edema, and later their complete disappearance
- Restoration of the amount of synovial fluid
- Restoration of mobility in diseased joints, reduction of morning stiffness
- Severe spasmolytic effect and lengthening of the remission period
Surgeons-traumatologists speak not only about significant shortening of the postoperative period, but also about reduction of the general medicamentous load on patient's body. The complex MeaPlasma allows reducing the number of analgesics and anti-inflammatory preparations, usually used to ease the pain syndrome, or even do without them.
Biological significance of use of the complex is expressed in valuable effects:
• Acceleration of regeneration processes - they take place at the cellular level
• Stimulation of formation of basic cells that build the bone, cartilaginous and connective tissue - fibroblasts, osteoblasts and chondrocytes
• Improvement of blood circulation due to increased growth of the capillary network
• Ensuring saturation of tissues with oxygen, their breathing
Another advantage of this regenerative complex is the possibility of simultaneous application with other conservative and surgical methods of treatment of diseases of the osteoarticular apparatus, physiotherapeutic procedures.
Due to what is the effect is achieved ?
The expression “bull's-eye” is explained one hundred percent by the properties of the product obtained from patient’s platelet plasma. You can get it easily if you have special equipment and supplies.
To do this, a small amount of blood (usually 20-25 ml) is taken with a syringe, then is placed in vacuum tubes and is centrifuged until platelet-rich autoplasma is obtained. In addition to a high content of platelets, it also consists of proteins, vitamins, hormones, without which the normal function of the joints is not possible.
The product is made in about 20 minutes, after which the obtained product is injected into the diseased joints:
Injection is made with a conventional muscle needle, and for the hip joint a special needle of 8-10 cm is required. After injection, a patch or an aseptic bandage is applied.
5-10 of such sessions are required, but after the first procedure a noticeable relief occurs - the pain subsides, there is less redness and edema. As the healing effect accumulates, improvements become even more pronounced, which can be considered a remission that lasts much longer than in case of standard treatment of bone and joint diseases.
For whom was the complex developed?
Patients with acute and chronic diseases of the musculoskeletal system represent the target group of MeaPlasma. The product is indicated for:
• Injuries to ligaments and muscles
• Tendovaginitis and other tendonitis
The course of treatment with autoplasma not only relieves pain, cramps and edema, but also strengthens the muscles adjacent to the joints, improves nutrition of articular cartilage, which is very valuable just like prevention of further development of existing diseases.
The regenerative complex MeaPlasma lacks many shortcomings of products used in the standard treatment of joint diseases. It is non-toxic, does not cause allergies, is completely absorbed by the body and it is well tolerated.
Contraindications to its use exist, but they are few:
• Thrombocytopenic conditions
• Malignant tumours
• Increased temperature of any etiology